Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite

PLoS ONE

Volumn 12, Issue 12, 2017, Pages

  Jaworska, Kinga ^a   Huc, Tomasz ^a   Samborowska, Emilia ^b   Dobrowolski, Leszek ^c   Bielinska, Klaudia ^a   Gawlak, Maciej ^a   Ufnal, Marcin ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; OCCLUDIN; PROTEIN ZO1; TRIMETHYLAMINE; METHYLAMINE; TRIMETHYLOXAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; GUT BLOOD BARRIER; HEPATIC CLEARANCE; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTESTINE BLOOD FLOW; INTESTINE MUCOSA PERMEABILITY; MALE; MORPHOMETRY; NONHUMAN; PERMEABILITY BARRIER; PROTEIN DETERMINATION; RAT; TIGHT JUNCTION; ANIMAL; BLOOD PRESSURE; COLON; INTESTINE MUCOSA; METABOLISM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; COLON; HYPERTENSION; INTESTINAL MUCOSA; MALE; METHYLAMINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 85038237708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0189310     Document Type: Article

References (30)

1. Ufnal M, Jazwiec R, Dadlez M, Drapala A, Sikora M, Skrzypecki J. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. The Canadian journal of cardiology. 2014; 30(12):1700–5. https://doi.org/10.1016/j.cjca.2014.09.010 PMID: 25475471.
2. Tomasova L, Konopelski P, Ufnal M. Gut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System Homeostasis. Molecules. 2016; 21(11). https://doi.org/10.3390/molecules21111558PMID: 27869680.
3. Wang Z, Tang WH, Buffa JA, Fu X, Britt EB, Koeth RA, et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. European heart journal. 2014; 35(14):904–10. https://doi.org/10.1093/eurheartj/ehu002 PMID: 24497336; PubMed Central PMCID: PMC3977137.
4. Matheson PJ, Wilson MA, Garrison RN. Regulation of intestinal blood flow. The Journal of surgical research. 2000; 93(1):182–96. https://doi.org/10.1006/jsre.2000.5862 PMID: 10945962.
5. Schmieder RE. End organ damage in hypertension. Deutsches Arzteblatt international. 2010; 107 (49):866–73. https://doi.org/10.3238/arztebl.2010.0866 PMID: 21191547; PubMed Central PMCID: PMC3011179.
6. Senthong V, Wang Z, Li XS, Fan Y, Wu Y, Tang WH, et al. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. Journal of the American Heart Association. 2016; 5(6). https://doi.org/10.1161/JAHA.115.002816 PMID: 27287696; PubMed Central PMCID: PMC4937244.
7. Nowinski A. Ufnal M. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases? Nutrition. 2018; 46:7–12. https://doi.org/10.1016/j.nut.2017.08.001
8. Kühn T, Rohrmann S, Sookthai D, Johnson T, Katzke V, Kaaks R, et al. Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year. Clinical Chemistry and Laboratory Medicine (CCLM). 2017; 55(2):261–8.
9. Zeisel SH, Wishnok JS, Blusztajn JK. Formation of methylamines from ingested choline and lecithin. The Journal of pharmacology and experimental therapeutics. 1983; 225(2):320–4. PMID: 6842395.
10. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature medicine. 2013; 19(5):576–85. https://doi.org/10.1038/nm.3145 PMID: 23563705; PubMed Central PMCID: PMC3650111.
11. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011; 472(7341):57–63. https://doi.org/10.1038/ nature09922 PMID: 21475195; PubMed Central PMCID: PMC3086762.
12. Bain MA, Fornasini G, Evans AM. Trimethylamine: metabolic, pharmacokinetic and safety aspects. Current drug metabolism. 2005; 6(3):227–40. PMID: 15975041.
13. Mansoor JK, Schelegle ES, Davis CE, Walby WF, Zhao W, Aksenov AA, et al. Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension. PloS one. 2014; 9(4):e95331. https://doi.org/10.1371/journal.pone.0095331 PMID: 24748102; PubMed Central PMCID: PMC3991617.
14. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature methods. 2012; 9(7):676–82. https://doi.org/10.1038/nmeth.2019 PMID: 22743772; PubMed Central PMCID: PMC3855844.
15. Tomasova L, Dobrowolski L, Jurkowska H, Wrobel M, Huc T, Ondrias K, et al. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric oxide: biology and chemistry. 2016; 60:50–8. https://doi.org/10.1016/j.niox.2016.09.007 PMID: 27667183.
16. Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Raber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. European heart journal. 2017. https://doi.org/10.1093/eurheartj/ehw582PMID: 28077467.
17. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016; 165(1):111–24. https://doi.org/10.1016/j.cell.2016.02.011 PMID: 26972052; PubMed Central PMCID: PMC4862743.
18. Yancey PH, Siebenaller JF. Co-evolution of proteins and solutions: protein adaptation versus cytopro-tective micromolecules and their roles in marine organisms. The Journal of experimental biology. 2015; 218(Pt 12):1880–96. https://doi.org/10.1242/jeb.114355 PMID: 26085665.
19. Ufnal M, Pham K. The gut-blood barrier permeability—A new marker in cardiovascular and metabolic diseases? Medical hypotheses. 2017; 98:35–7. https://doi.org/10.1016/j.mehy.2016.11.012 PMID: 28012600.
20. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. Journal of gastroenterology and hepatology. 2003; 18(5):479–97. PMID: 12702039.
21. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. The Journal of allergy and clinical immunology. 2009; 124(1):3–20; quiz 1–2. https://doi.org/10.1016/j.jaci.2009.05.038 PMID: 19560575; PubMed Central PMCID: PMC4266989.
22. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, et al. Altered intestinal function in patients with chronic heart failure. Journal of the American College of Cardiology. 2007; 50 (16):1561–9. https://doi.org/10.1016/j.jacc.2007.07.016 PMID: 17936155.
23. Santisteban MM, Qi Y, Zubcevic J, Kim S, Yang T, Shenoy V, et al. Hypertension-Linked Pathophysio-logical Alterations in the Gut. Circulation research. 2017; 120(2):312–23. https://doi.org/10.1161/CIRCRESAHA.116.309006 PMID: 27799253; PubMed Central PMCID: PMC5250568.
24. Meijers BK, Evenepoel P. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2011; 26(3):759–61. https://doi.org/10.1093/ndt/gfq818 PMID: 21343587.
25. Washington C, Carmichael JC. Management of ischemic colitis. Clinics in colon and rectal surgery. 2012; 25(4):228–35. https://doi.org/10.1055/s-0032-1329534 PMID: 24294125; PubMed Central PMCID: PMC3577613.
26. Fink MP, Kaups KL, Wang HL, Rothschild HR. Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery. 1991; 110(2):154–60; discussion 60–1. PMID: 1907030.
27. Thuijls G, de Haan JJ, Derikx JP, Daissormont I, Hadfoune M, Heineman E, et al. Intestinal cytoskeleton degradation precedes tight junction loss following hemorrhagic shock. Shock. 2009; 31(2):164–9. https://doi.org/10.1097/SHK.0b013e31817fc310 PMID: 18650780.
28. Mishra RC, Tripathy S, Gandhi JD, Balsevich J, Akhtar J, Desai KM, et al. Decreases in splanchnic vascular resistance contribute to hypotensive effects of L-serine in hypertensive rats. American journal of physiology Heart and circulatory physiology. 2010; 298(6):H1789–96. https://doi.org/10.1152/ajpheart.00810.2009 PMID: 20348218.
29. Sawada N. Tight junction-related human diseases. Pathology international. 2013; 63(1):1–12. https://doi.org/10.1111/pin.12021 PMID: 23356220.
30. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49(6):1877–87. https://doi.org/10.1002/hep.22848 PMID: 19291785.